MLR-1023 Treatment in Mice and Humans Induces a Thermogenic Program, and Menthol Potentiates the Effect

A glucose-lowering medication that acts by a different mechanism than metformin, or other approved diabetes medications, can supplement monotherapies when patients fail to meet blood glucose goals. We examined the actions underlying the effects of an insulin sensitizer, tolimidone (MLR-1023) and inv...

Full description

Saved in:
Bibliographic Details
Main Authors: Candida J. Rebello, Ann A. Coulter, Andrew G. Reaume, Weina Cong, Luke A. Cusimano, Frank L. Greenway
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
R
Online Access:https://doaj.org/article/4516d1342a1f4ef69cc538ba787de368
Tags: Add Tag
No Tags, Be the first to tag this record!